Browse by all authors Browse By Author ID - Mollee, Peter

Browse Results (92 results found)

Subscribe to the RSS feed for this result setSubscribe to the RSS feed for this result set

Page 1 of 2

Result Pages:    1 2  next › last »

Refine

  Abstract Views File Downloads Thomson Reuters Web of Science Citation Count Scopus Citation Count Altmetric Score
Lane, Steven, Saal, Russell, Mollee, Peter, Jones, Mark, Grigg, Andrew, Taylor, Kerry, Seymour, John, Kennedy, Glen, Williams, Bronwyn, Grimmett, Karen, Griffiths, Vanessa, Gill, Devinder, Hourigan, Matthew and Marlton, Paula (2008) A 1 log rise in RQ-PCR transcript levels defines molecular relapse in core binding factor accute myeloid leukemia and predicts subsequent morphologic relapse. Leukemia & Lymphoma, 49 3: 517-523. doi:10.1080/10428190701817266 147   21 Cited 18 times in Scopus18 0
Middleton, HJ, Mollee, P, Bird, R, Mills, AK, Marlton, P and Gill, D (2005). Accelerated delivery of Rituximab is safe on an out-patient basis.. In: Blood. 47th Annual Meeting of the American-Society-of-Hematology, Atlanta Ga, (274B-274B). Dec 10-13, 2005. 77   0
Durrant, S, Szer, J, Bradstock, K, Nivison-Smith, I and Mollee, P (2002). Allogeneic stem cell transplantation for idiopathic myelofibrosis in Australasia. In: Bone Marrow Transplantation. , , (S165-S166). . 25   0
Rifkind, Joshua, Mollee, Peter, Messner, Hans and Lipton, Jeffrey (2005) Allogeneic stem cell transplantation for mantle cell lymphoma--does it deserve a better look?. Leukemia & Lymphoma, 46 2: 217-223. doi:10.1080/10428190400015022 65   4 Cited 4 times in Scopus4 0
Tate, Jillian R., Mollee, Peter, Dimeski, Goce, Carter, Andrew C. and Gill, Devinder (2007) Analytical performance of serum free light-chain assay during monitoring of patients with monoclonal light-chain diseases. Clinica Chimica Acta, 376 1-2: 30-36. doi:10.1016/j.cca.2006.07.011 68   48 Cited 60 times in Scopus60 0
Tate, Jillian R., Mollee, Peter, Dimeski, Goce, Carter, Andrew C. and Gill, Devinder (2007) Analytical performance of serum free light-chains assay. Clinica Chimica Acta, 380 1-2: 250-251. doi:10.1016/j.cca.2007.02.004 22   0 Cited 4 times in Scopus4 0
Hourigan, Matthew J., Doecke, James, Mollee, Peter N., Gill, Devinder S., Norris, Debra, Johnson, David W. and Gandhi, Maher K. (2008) A new prognosticator for post-transplant lymphoproliferative disorders after renal transplantation. British Journal of Haematology, 141 6: 904-907. doi:10.1111/j.1365-2141.2008.07149.x 83   12 Cited 12 times in Scopus12 0
Mollee, P., Taylor, K., Arthur, C., Wright, S., Rodwell, R. and Taylor, D. (2000). A Phase II study of Interferon alpha and intermittent oral Cytarabine in the treatment of newly diagnosed Chronic Myeloid Leukaemia.. In: Proceedings of the 2nd Annual Scientific Meeting of the Haematology Society of Australia and New Zealand. , Perth, (). July 2000. 49  
Mollee, P., Taylor, K., Arthur, C., Wright, S. and Morton, J. (2000). A phase II study of interferon alpha (IFN) and intermittent oral cytarabine (YNK01) in the treatment of newly diagnosed chronic myeloid leukemia (CML). In: Blood: The 2nd Annual Scientific Meeting of the Haematology Society of Australia and New Zealand. 2nd Annual Scientific Meeting of the Haematology Society of Australia and New Zealand, Perth, WA, (545A-545A). 25-28 July 2000. 185   4
Mollee, Peter, Tiley, Campbell, Cunningham, Ilona, Moore, John, Prince, H.Miles, Cannell, Paul, Gibbons, Steve, Tate, Jill, Paul, Sanjoy, Fan, Helen Mar and Gill, Devinder S. (2012) A phase II study of risk-adapted intravenous melphalan in patients with AL amyloidosis. British Journal of Haematology, 157 6: 766-769. doi:10.1111/j.1365-2141.2012.09080.x 57   3 Cited 3 times in Scopus3 1
Kuruvilla, John, Song, Kevin, Mollee, Peter, Panzarella, Tony, McCrae, Jan, Nagy, Tracy, Crump, Michael and Keating, Armand (2006) A phase II study of thalidomide and vinblastine for palliative patients with Hodgkin's lymphoma. Hematology, 11 1: 25-29. doi:10.1080/10245330500276592 84   Cited 15 times in Scopus15 0
Kuruvilla, John, Song, Kevin, Mollee, Peter, Panzarella, Tony, McCrae, Jan, Nagy, Tracy, Crump, Michael and Keating, Armand (2006) A phase II study of thalidomide and vinblastine for palliative patients with Hodgkin's lymphoma. Hematology, 11 1: 25-29. doi:10.1080/10245330500276592 33   10 Cited 15 times in Scopus15 0
Kuruvilla, J., Mollee, P., Song, K., Zaretsky, Y., Panzarella, T., McCrae, J., Nagy, T., Crump, M. and Keating, A. (2005). A phase II study of thalidomide and vinblastine for palliative patients with Hodgkin's lymphoma. In: Abstracts of the 9th International Conference on Malignant Lymphoma. 9th International Conference on Malignant Lymphoma, Lugano, Switzerland, (198-198). 9 -11 June 2005. doi:10.1093/annonc/mdi582 24   0 0
Mollee, P., Tate, J., Weiss, D. and Solomon, A. (2010). Assessment of a monoclonal antibody-based free light chain enzyme-linked immunosorbent assay (ELISA) and the polyclonal antibody-based Freelite assay in AL amyloidosis. In: Abstracts of the 12th International Symposium on Amyloidosis from Molecular Mechanisms Toward the Cure of Systemic Amyloidoses. 12th International Symposium on Amyloidosis from Molecular Mechanisms Toward the Cure of Systemic Amyloidoses, Rome, Italy, (198-199). 18-21, April 2010. 37   0
Mollee, P, Song, K, Keating, A, Tsang, R and Crump, M (2002). Autologous stem cell transplantation (ASCT) for relapsed/refractory follicular large cell lymphoma (FLCL).. In: Blood. 44th Annual Meeting of the American-Society-of-Hematology, Philadelphia Pennsylvania, (183A-183A). Dec 06-10, 2002. 32   0
Mollee, P. N., Wechalekar, A. D., Pereira, D. L., Franke, N., Reece, D., Chen, C. and Stewart, A. K. (2004) Autologous stem cell transplantation in primary systemic amyloidosis: the impact of selection criteria on outcome. Bone Marrow Transplantation, 33 3: 271-277. doi:10.1038/sj.bmt.1704344 61   40 Cited 43 times in Scopus43 0
Song, Kevin W., Mollee, Peter, Keating, Amanda and Crump, Michael (2003) Autologous stem cell transplant for relapsed and refractory peripheral T-cell lymphoma: variable outcome according to pathological subtype. British Journal of Haematology, 120 6: 978-985. doi:10.1046/j.1365-2141.2003.04203.x 65   63 Cited 79 times in Scopus79 0
Marshall, George, Tate, Jill and Mollee, P. (2009) Borderline High Serum Free Light Chain κ/λ Ratios Are Seen Not Only in Dialysis Patients but Also in Non–Dialysis-Dependent Renal Impairment and Inflammatory States. American Journal of Clinical Pathology, 132 2: 309-309. doi:10.1309/AJCP8VOT5TVLAQBQ 32   9 Cited 10 times in Scopus10 0
Mollee, P., Jones, M., Stackelroth, J., van Kuilenburg, R., Joubert, W., Faoagali, J., Looke, D., Harper, J. and Clements, A. (2011) Catheter-associated bloodstream infection incidence and risk factors in adults with cancer: A prospective cohort study. Journal of Hospital Infection, 78 1: 26-30. doi:10.1016/j.jhin.2011.01.018 97 3 26 Cited 29 times in Scopus29 0
Mollee, Peter, Jones, Mark, Stackelroth, Jenny, van Kuilenburg, Rosita, Joubert, Warren, Faoagali, Joan, Looke, David, Harper, John and Clements, Archie (2009). Catheter-associated bloodstream infection incidence and risk factors in adults with cancer: A prospective cohort study. In: ASH Annual Meeting Abstracts. 51st ASH Annual Meeting and Exposition, New Orleans, LA, U.S.A., (563-563). 5-8 December 2009. 147   0
Burgess, Melinda, Cheung, Catherine, Chambers, Lynne, Ravindranath, Karunya, Minhas, Gunjeet, Knop, Louise, Mollee, Peter, McMillan, Nigel A. J. and Gill, Devinder (2012) CCL2 and CXCL2 enhance survival of primary chronic lymphocytic leukemia cells in vitro. Leukemia and Lymphoma, 53 10: 1988-1998. doi:10.3109/10428194.2012.672735 77   11 Cited 8 times in Scopus8 0
Lane, SW, Saal, R, Negus, S, Mollee, P, Mather, M, Gill, D, Mills, AK, Bird, RJ, Hourigan, MJ, Jones, M and Marlton, P (2006). Characterisation and prognostic significance of WT-1 gene expression in acute myeloid leukemia (AML).. In: Blood. 48th Annual Meeting of the American-Society-of-Hematology, Orlando Fl, (655A-655A). Dec 09-12, 2006. 45   0
Tate, J.R., Mollee, P., Carter, A. and Gill, D. (2006). Clinical utility and technical pitfalls of the serum free light chain (FLC) assay for monitoring of monoclonal light-chain diseases. In: 2006 Annual Meeting Abstracts. 58th Annual Meeting of the American Association of Clinical Chemistry, Chicago, IL, United States, (A178-A178). 23-27 July 2006. 32   0
Mollee, P, Morton, J, Irving, I and Durrant, S (2000). Combination therapy with antithymocyte globulin (ATG) and tacrolimus for patients with steroid refractory GVHD.. In: Blood. , , (400A-400A). . 21   0
Mollee, Peter (2009) Current trends in the diagnosis, therapy and monitoring of the monoclonal gammopathies. Clinical Biochemist Reviews, 30 3: 93-103. 54  
Morris, K. L., Tate, J. R., Gill, D., Kennedy, G., Wellwood, J., Marlton, P., Bird, R., Mills, A. K. and Molle, P. (2007) Diagnostic and prognostic utility of the serum free light chain assay in patients with AL amyloidosis. Internal Medicine Journal, 37 7: 456-463. doi:10.1111/j.1445-5994.2007.01368.x 76   18 Cited 24 times in Scopus24 0
Mollee, P, Nagy, T, Saragosa, R, Turner, R, Keating, A and Crump, M (2002). Effect of gemcitabine, dexamethasone and cisplatin salvage chemotherapy (GDP) on peripheral blood stem cell (PBSC) mobilization in patients with lymphoma.. In: Blood. 44th Annual Meeting of the American-Society-of-Hematology, Philadelphia Pennsylvania, (828A-828A). Dec 06-10, 2002. 36   0
Dimeski, Goce, Mollee, Peter and Carter, Andrew (2006) Effects of hyperlipidemia on plasma sodium, potassium, and chloride measurements by an indirect ion-selective electrode measuring system. Clinical Chemistry, 52 1: 155-156. doi:10.1373/clinchem.2005.054981 96   13 Cited 15 times in Scopus15 0
Trappe, R., Choquet, S., Oertel, S., LeBlond, V., Ekman, T., Sender, M., Mollee, P, Reinke, P., Lehmkuhl, H., Hummel, M., Jonas, S., Neuhaus, R., Salles, G., Morschhauser, F., Jaccard, A., Anagnostopoulos, I., Raphael, M. and Riess, H. (2007). Efficacy and safety of sequential treatment with rituximab and CHOP chemotherapy in B-cell PTLD: Results of a prospective international phase II study. In: American Transplant Congress abstracts. Annual American Transplant Congress, San Francisco, CA, United States, (317-317). 5 - 9 May 2007. doi:10.1111/j.1600-6143.2007.01811.x 34   0 0
Nehring, Angela K., Dua, Ujjwal, Mollee, Peter, Gill, Devinder, Grimmett, Karen, Khanna, Rajiv, Moss, Denis and Gandhi, Maher K. (2007) Epstein-Barr virus T-cell immunity despite rituximab. British Journal of Haematology, 136 4: 628-632. doi:10.1111/j.1365-2141.2006.06482.x 88   8 Cited 9 times in Scopus9 0
Mollee, Peter, Tate, Jill and Pretorius, Carel J. (2013) Evaluation of the N Latex free light chain assay in the diagnosis and monitoring of AL amyloidosis. Clinical Chemistry and Laboratory Medicine, 51 12: 2303-2310. doi:10.1515/cclm-2013-0361 13   4 Cited 6 times in Scopus6 2
Mollee, Peter, Tate, Jill, Dimeski, Goce and Gill, Devinder (2005). Falsely low serum free light chain concentration in patients with monoclonal light chain diseases. In: ASH Annual Meeting Abstracts, 2005. 47th Annual Meeting of the American-Society-of-Hematology, Atlanta, GA, United States, (351-351). 10-13 December 2005. 29   0
Tate, J.R., Mollee, P., Dimeski, G. and Gill, D. (2005). Falsely low serum free light chain concentration in patients with monoclonal light chain diseases. In: 2005 Annual Meeting Abstracts. Annual Meeting of the American Association Clinical Chemistry, Orlando, FL, United States, (A60-A60). 24-28 July 2005. 36   0
Sugnanam, K., Ooi, L., Mollee, P. and Vu, P. (2012) Gamma-delta T-cell lymphoma with CNS involvement presenting with proptosis: A case study workup, treatment and prognosis. Orbit, 31 5: 364-366. doi:10.3109/01676830.2012.711411 48 2 Cited 1 times in Scopus1 0
Lane, S. W., Goodman, H. J., Francis, L., Bofinger, A. M. and Mollee, P. N. (2006) Hereditary fibrinogen A alpha-chain amyloidosis. Pathology, 38 4: 380-382. doi:10.1080/00313020600820823 57   5 Cited 5 times in Scopus5 0
Mutsando, Howard, Fahim, Magid, Gill, Devinder S., Hawley, Carmel M., Johnson, David W., Maher, K. Gandhi, Marlton, Paula V., Mar Fan, Helen G. and Mollee, Peter N. (2012) High dose methotrexate and extended hours high-flux hemodialysis for the treatment of primary central nervous system lymphoma in a patient with end stage renal disease. American Journal of Blood Research, 2 1: 66-70. 44 3
Keane, C., Nourse, J. P., Crooks, P., Nguyen-Van, D., Mutsando, H., Mollee, P., Lea, R. A. and Gandhi, M. K. (2012) Homozygous FCGR3A-158V alleles predispose to late onset neutropenia after CHOP-R for diffuse large B-cell lymphoma. Internal Medicine Journal, 42 10: 1113-1119. doi:10.1111/j.1445-5994.2011.02587.x 48   2 Cited 6 times in Scopus6 4
Mollee, P., Renaut, P., Gottlieb, D. and Goodman, H. (2014) How to diagnose amyloidosis. Internal Medicine Journal, 44 1: 7-17. doi:10.1111/imj.12288 31   1 Cited 2 times in Scopus2 2
Gill, Devinder, Burgess, Melinda, Knop, Louise, Mollee, Peter and McMillan, Nigel (2008). Identification of two novel chemokines (CCL2 and CXCL2) in B-chronic lymphocytic leukaemia (B-CLL) and prolonged survival of primary B-CLL cells in vitro. In: ASH Annual Meeting Abstracts, 20098. 50th Annual Meeting of the American- Society-of-Hematology, San Francisco, CA, United States, (1082-1083). 6 - 9 December 2008. 43   0
Gandhi, M., Wilkie, G. M., Dua, U., Mollee, P., Grimmett, K., Williams, T., Whitaker, N., Gill, D. and Crawford, D. (2007) Immunity, homing and efficacy of allogeneic adoptive immunotherapy for posttransplant lymphoproliferative disorders. American Journal of Transplantation, 7 5: 1293-1299. doi:10.1111/j.1600-6143.2007.01796.x 63   31 Cited 28 times in Scopus28 0
Mollee, P, Hourigan, M, Johnson, D, Jones, M, Isabel, N, Hawley, C, Marlton, P, Gandhi, M, Campbell, S and Gill, D (2007). Immunosuppression (IST) can be safely ceased during chemotherapy for PTLD in renal transplant patients. In: Blood. 49th Annual Meeting of the American-Society-of-Hematology, Atlanta Ga, (410A-411A). Dec 08-11, 2007. 29   0
Hourigan, Matthew J., Johnson, David W., Jones, Mark, Gill, Devinder S., Isbel, Nikki, Hawley, Carmel M., Marlton, Paula, Gandhi, Maher, Campbell, Scott B. and Mollee, Peter (2007). Immunosuppression (IST) can be safely ceased during chemotherapy for PTLD in renal transplant patients. In: American Journal of Transplantation. American Transplant Congress, San Francisco, CA, USA, (399-399). 5-9 May 2007. doi:10.1111/j.1600-6143.2007.01811.x 82   0 0
Hourigan, Matthew J., Johnson, David W., Jones, Mark, Gill, Devinder S., Isbel, Nikki, Hawley, Carmel M., Marlton, Paula, Ghandhi, Maher, Campbell, Scott B. and Mollee, Peter (2007). Immunosuppression (IST) Can Be Safely Ceased during Chemotherapy for PTLD in Renal Transplant Patients. In: P. Halloran, American Journal of Transplantation: Proceedings of the American Transplant Congress 2007. American Transplant Congress 2007, USA, (399-399). 5-9 May 2007. doi:10.1111/j.1600-6143.2007.01811.x 156   0 0
Dimeski, Goce, Mollee, Peter and Carter, Andrew (2005) Increased Lipid Concentration Is Associated with Increased Hemolysis. Clinical Chemistry, 51 12: 2425-2425. doi:10.1373/clinchem.2005.058644 23   6 Cited 5 times in Scopus5 0
Lane, Steven W., Marlton, Paula and Mollee, Peter N. (2006) Increased Mortality with FLA Compared with ADE Chemotherapy in High-risk AML (Letter to the Editor). Blood, 108 12: 3950-3951. doi:10.1182/blood-2006-06-032680 50   0 Cited 0 times in Scopus0 0
Mollee, P., Arthur, C., Hughes, T., Januszewicz, H., Grigg, A., Bradstock, K., Wolf, M., Gibson, J., Schwarer, A. P., Spencer, A., Browett, P., Hawkins, T., Seldon, M., Herrmann, R. and Watson, A. (2004) Interferon-α-2b and oral cytarabine ocfosfate for newly diagnosed chronic myeloid leukaemia. Annals of Oncology, 15 12: 1810-1815. doi:10.1093/annonc/mdh468 59   3 Cited 4 times in Scopus4 0
Weston, H, Bird, R, Griffiths, V, Jones, M, Grimmett, K, Saal, R, Mills, AK, Gill, D, Marlton, P and Mollee, P (2007). JAK2V617F mutation status predicts thrombotic complications, including arterial thrombosis, in patients with essential thrombocytosis (ET). In: Blood. 49th Annual Meeting of the American-Society-of-Hematology, Atlanta Ga, (752A-752A). Dec 08-11, 2007. 44   0
Mollee, P., Gupta, V., Song, K., Reddy, V., Califaretti, N., Tsang, R., Crump, M. and Keating, A. (2004) Long-term outcome after intensive therapy with etoposide, melphalan, total body irradiation and autotransplant for acute myeloid leukemia. Bone Marrow Transplantation, 33 12: 1201-1208. doi:10.1038/sj.bmt.1704506 51   9 Cited 11 times in Scopus11 0
Mollee, P, Gupta, V, Song, K, Tsang, R, Crump, M and Keating, A (2002). Long-term outcome following high-dose therapy with etoposide, melphalan, TBI and autologous stem cell transplantation (ASCT) for acute myeloid leukemia (AML).. In: Blood. 44th Annual Meeting of the American-Society-of-Hematology, Philadelphia Pennsylvania, (862A-862A). Dec 06-10, 2002. 19   0
Irving, I, Williamson, J, Mollee, P, Morton, AJ, Sloots, T, Siebert, D and Durrant, S (2001). Low dose valaciclovir for the prevention of CMV disease post allogeneic bone marrow transplantation. In: Bone Marrow Transplantation. , , (S154-S155). . 17   0

Page 1 of 2

Result Pages:    1 2  next › last »